MyoR	O
modulates	O
cardiac	O
conduction	O
by	O
repressing	O
Gata4	O
.	O


The	O
cardiac	O
conduction	O
system	O
coordinates	O
electrical	O
activation	O
through	O
a	O
series	O
of	O
interconnected	O
structures	O
,	O
including	O
the	O
atrioventricular	O
node	O
(	O
AVN	O
)	O
,	O
the	O
central	O
connection	O
point	O
that	O
delays	O
impulse	O
propagation	O
to	O
optimize	O
cardiac	O
performance	O
.	O


Although	O
recent	O
studies	O
have	O
uncovered	O
important	O
molecular	O
details	O
of	O
AVN	O
formation	O
,	O
relatively	O
little	O
is	O
known	O
about	O
the	O
transcriptional	O
mechanisms	O
that	O
regulate	O
AV	O
delay	O
,	O
the	O
primary	O
function	O
of	O
the	O
mature	O
AVN	O
.	O


We	O
identify	O
here	O
MyoR	O
as	O
a	O
novel	O
transcription	O
factor	O
expressed	O
in	O
Cx30	O
.	O
2	O
(	O
+	O
)	O
cells	O
of	O
the	O
AVN	O
.	O


We	O
show	O
that	O
MyoR	O
specifically	O
inhibits	O
a	O
Cx30	O
.	O
2	O
enhancer	O
required	O
for	O
AVN	O
-	O
specific	O
gene	O
expression	O
.	O


Furthermore	O
,	O
we	O
demonstrate	O
that	O
MyoR	O
interacts	O
directly	O
with	O
Gata4	O
to	O
mediate	O
transcriptional	O
repression	O
.	O


Our	O
studies	O
reveal	O
that	O
MyoR	O
contains	O
two	O
nonequivalent	O
repression	O
domains	O
.	O


While	O
the	O
MyoR	O
C	O
-	O
terminal	O
repression	O
domain	O
inhibits	O
transcription	O
in	O
a	O
context	O
-	O
dependent	O
manner	O
,	O
the	O
N	O
-	O
terminal	O
repression	O
domain	O
can	O
function	O
in	O
a	O
heterologous	O
context	O
to	O
convert	O
the	O
Hand2	O
activator	O
into	O
a	O
repressor	O
.	O


In	O
addition	O
,	O
we	O
show	O
that	O
genetic	O
deletion	O
of	O
MyoR	O
in	O
mice	O
increases	O
Cx30	O
.	O
2	O
expression	O
by	O
50	O
%	O
and	O
prolongs	O
AV	O
delay	O
by	O
13	O
%	O
.	O


Taken	O
together	O
,	O
we	O
conclude	O
that	O
MyoR	O
modulates	O
a	O
Gata4	O
-	O
dependent	O
regulatory	O
circuit	O
that	O
establishes	O
proper	O
AV	O
delay	O
,	O
and	O
these	O
findings	O
may	O
have	O
wider	O
implications	O
for	O
the	O
variability	O
of	O
cardiac	O
rhythm	O
observed	O
in	O
the	O
general	O
population	O
.	O
